71 related articles for article (PubMed ID: 16813607)
1. Frequency and nature of hMSH6 germline mutations in Polish patients with colorectal, endometrial and ovarian cancers.
Suchy J; Kurzawski G; Jakubowska K; Rać ME; Safranow K; Kładny J; Rzepka-Górska I; Chosia M; Czeszyńska B; Oszurek O; Scott RJ; Lubiński J
Clin Genet; 2006 Jul; 70(1):68-70. PubMed ID: 16813607
[No Abstract] [Full Text] [Related]
2. Familial endometrial cancer in female carriers of MSH6 germline mutations.
Wijnen J; de Leeuw W; Vasen H; van der Klift H; Møller P; Stormorken A; Meijers-Heijboer H; Lindhout D; Menko F; Vossen S; Möslein G; Tops C; Bröcker-Vriends A; Wu Y; Hofstra R; Sijmons R; Cornelisse C; Morreau H; Fodde R
Nat Genet; 1999 Oct; 23(2):142-4. PubMed ID: 10508506
[No Abstract] [Full Text] [Related]
3. Ovarian cancer of endometrioid type as part of the MSH6gene mutation phenotype.
Suchy J; Kurzawski G; Jakubowska A; Lubiński J
J Hum Genet; 2002; 47(10):529-31. PubMed ID: 12376742
[TBL] [Abstract][Full Text] [Related]
4. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer.
Miyaki M; Konishi M; Tanaka K; Kikuchi-Yanoshita R; Muraoka M; Yasuno M; Igari T; Koike M; Chiba M; Mori T
Nat Genet; 1997 Nov; 17(3):271-2. PubMed ID: 9354786
[No Abstract] [Full Text] [Related]
5. The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype.
Albarracin CT; Silva EG; Malpica A; Luthra R; Liu J
Oncol Rep; 2004 Dec; 12(6):1217-9. PubMed ID: 15547740
[TBL] [Abstract][Full Text] [Related]
6. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.
Brozek I; Ochman K; Debniak J; Morzuch L; Ratajska M; Stepnowska M; Stukan M; Emerich J; Limon J
Gynecol Oncol; 2008 Feb; 108(2):433-7. PubMed ID: 17997147
[TBL] [Abstract][Full Text] [Related]
7. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin.
Abdel-Rahman WM; Kalinina J; Shoman S; Eissa S; Ollikainen M; Elomaa O; Eliseenkova AV; Bützow R; Mohammadi M; Peltomäki P
Hum Mutat; 2008 Mar; 29(3):390-7. PubMed ID: 18165946
[TBL] [Abstract][Full Text] [Related]
8. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
[TBL] [Abstract][Full Text] [Related]
10. Mutation of TCF1 encoding hepatocyte nuclear factor 1alpha in gynecological cancer.
Rebouissou S; Rosty C; Lecuru F; Boisselier S; Bui H; Le Frere-Belfa MA; Sastre X; Laurent-Puig P; Zucman-Rossi J
Oncogene; 2004 Sep; 23(45):7588-92. PubMed ID: 15326484
[TBL] [Abstract][Full Text] [Related]
11. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.
Imai K; Yamamoto H
Carcinogenesis; 2008 Apr; 29(4):673-80. PubMed ID: 17942460
[TBL] [Abstract][Full Text] [Related]
13. [Lynch syndrome and gynaecologic's cancer: follow-up recommendations].
Magri K; Millon G
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):68-71. PubMed ID: 17293255
[TBL] [Abstract][Full Text] [Related]
14. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the hMSH6 gene in familial and early-onset colorectal and endometrial cancer in Israeli patients.
Figer A; Kaplan A; Geva R; Flex D; Yaron M; Levy T; Sapir EE; Fidder HH; Friedman E
Genet Test; 2002; 6(4):323-6. PubMed ID: 12537658
[TBL] [Abstract][Full Text] [Related]
16. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
17. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study.
Jo H; Kang S; Kim SI; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP
Gynecol Obstet Invest; 2007; 64(2):84-8. PubMed ID: 17314486
[TBL] [Abstract][Full Text] [Related]
18. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
19. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
20. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
Croitoru ME; Cleary SP; Berk T; Di Nicola N; Kopolovic I; Bapat B; Gallinger S
J Surg Oncol; 2007 May; 95(6):499-506. PubMed ID: 17219385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
